Growth Equity Opportunities Fund, LLC Insider Trading
Get free email notifications about insider trading for Growth Equity Opportunities Fund, LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Growth Equity Opportunities Fund, LLC. Growth Equity Opportunities Fund, LLC is a 10% Owner in SUNESIS PHARMACEUTICALS INC ($SNSS) and a 10% Owner in ARYx Therapeutics, Inc. ($ARYX).
Address: 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM 21093 MD
Companies in which Growth Equity Opportunities Fund, LLC is an Insider
ARYx Therapeutics, Inc.
Trading Symbol: ARYXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Growth Equity Opportunities Fund, LLC: 10% Owner
Holdings: 0 shares
Current Value: $0
Latest Transaction: Mar 14 2011
$ARYX Market Capitalization: $117113.50
$ARYX Previous Close: $0.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Viracta Therapeutics, Inc.
Trading Symbol: SNSSIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Growth Equity Opportunities Fund, LLC: 10% Owner
Holdings: 4,659,333 shares
Current Value: $19,103,265
Latest Transaction: Aug 29 2014
$SNSS Market Capitalization: $85.18M
$SNSS Previous Close: $4.10
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Growth Equity Opportunities Fund, LLC
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 29 2014 | SNSS | SUNESIS PHARMACEUT ... | Growth Equity Opportunities Fu ... | 10% Owner | Sell | S | 7.51 | 11,600 | 87,070 | 4,659,333 | 4.7 M to 4.7 M (-0.25 %) |
Aug 29 2014 | SNSS | SUNESIS PHARMACEUT ... | Growth Equity Opportunities Fu ... | 10% Owner | Sell | S | 7.87 | 146,800 | 1,154,846 | 4,670,933 | 4.8 M to 4.7 M (-3.05 %) |
Aug 29 2014 | SNSS | SUNESIS PHARMACEUT ... | Growth Equity Opportunities Fu ... | 10% Owner | Sell | S | 8.17 | 108,300 | 884,811 | 4,817,733 | 4.9 M to 4.8 M (-2.20 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | Growth Equity Opportunities Fu ... | 10% Owner | Sell | S | 6.76 | 35,540 | 240,190 | 4,926,033 | 5 M to 4.9 M (-0.72 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | Growth Equity Opportunities Fu ... | 10% Owner | Sell | S | 6.62 | 675,000 | 4,468,568 | 4,961,573 | 5.6 M to 5 M (-11.98 %) |
Mar 14 2011 | ARYX | ARYx Therapeutics, ... | Growth Equity Opportunities Fu ... | 10% Owner | Sell | S | 0.07 | 4,469,274 | 326,257 | 0 | 4.5 M to 0 (-100.00 %) |
Mar 14 2011 | ARYX | ARYx Therapeutics, ... | Growth Equity Opportunities Fu ... | 10% Owner | Sell | S | 0.07 | 4,469,274 | 326,257 | 0 | 4.5 M to 0 (-100.00 %) |
View all Growth Equity Opportunities Fund, LLC insider transactions.